As part of our continuous effort to enhance efficiency in healthcare delivery, we are transitioning from using a paper-based ‘Report of suspected adverse drug reaction ADR01’ form to an electronic version in the EMR (electronic medical record).
This change allows us to:
- Consolidate reporting of patient adverse reactions, ensuring this information is available in the patient’s health record, and
- Streamline the adverse reaction reporting process within the organisation and to relevant external organisations and health professionals.
Effective next Tuesday 12 December, suspected adverse reactions due to new medicines will be reported via the EMR for patients with an active EMR encounter. For these patients, this process replaces the existing use of the ‘Report of suspected adverse drug reaction ADR01’ paper form.
Key points if a patient experiences an adverse reaction
For patients with an active EMR encounter
- Update the patient’s information in the EMR banner bar
- Select the hospital encounter that the adverse reaction occurred
- Report the adverse reaction by creating the ‘Report of Suspected Adverse Reaction to Medicines/Vaccines’ PowerForm in the EMR:
- Click on ‘AdHoc’ on the EMR banner bar
- Select ‘Report of Suspected Adverse Reaction to Medicines/Vaccines’
- Click on ‘Chart’
- Complete the fields on the ‘Report of Suspected Adverse Reaction to Medicines/Vaccines’ form. The yellow fields are mandatory fields.
- Sign the form by clicking on the green tick on the top of the navigation bar for the ‘Report of Suspected Adverse Reaction to Medicines/Vaccines’ to save the finalised form. Select ‘Sign’ when asked if you would like to continue.
Note: The form may be edited or modified after it has been signed.
- Go to ‘Documentation’ in the EMR menu to locate a completed ‘Report of Suspected Adverse Reaction to Medicines/Vaccines’ form.
For patients without an active EMR encounter (e.g. outpatients)
- Update the patient’s adverse reaction information in the EMR banner bar
- Continue to report suspected adverse reactions via:
- RiskMan
- Pharmacy intranet site (select ‘Adverse Drug Reaction Reporting‘) or
- ‘Report of Suspected Adverse Drug Reaction’ paper form (ADR01) – available from Pharmacy Department and send the completed form to the ADR pharmacist via internal mail
For further questions
Please contact the medication safety team via email (medicationsafety@monashhealth.org) or extension x43668.
The Allergies and Adverse Drug Reactions (ADRs): Reporting a New Reaction Procedure on PROMPT will be updated to incorporate this new information.
Approved by Sue Kirsa, Director of Pharmacy